Nasal administration of anti-CD3 monoclonal antibody ameliorates disease in a mouse model of Alzheimer’s disease 🔗 Access full article via PNAS Immunology and InflammationShare:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon
